title: Is there material hazard to treatment with intravenous iron?
authors.affiliation: Winthrop-University Hospital, Mineola, NY, USA.
authors.forename: S
authors.initials: S
authors.lastname: Fishbane
authors.forename: J K
authors.initials: JK
authors.lastname: Maesaka
authors.forename: S K
authors.initials: SK
authors.lastname: Mittal
mesh_terms: D000740:Anemia / Q000188:drug therapy; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use; D006400:Hematocrit; D006801:Humans; D007275:Injections, Intravenous; D007501:Iron / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D000090463:Iron Deficiencies; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D006435:Renal Dialysis
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin; D007501:Iron